These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Development of lupus-related side-effects in patients with early RA during sulphasalazine treatment-the role of IL-10 and HLA. Gunnarsson I, Nordmark B, Hassan Bakri A, Gröndal G, Larsson P, Forslid J, Klareskog L, Ringertz B. Rheumatology (Oxford); 2000 Aug; 39(8):886-93. PubMed ID: 10952745 [Abstract] [Full Text] [Related]
3. Does sulphasalazine cause drug induced systemic lupus erythematosus? No effect evident in a prospective randomised trial of 200 rheumatoid patients treated with sulphasalazine or auranofin over five years. Gordon MM, Porter DR, Capell HA. Ann Rheum Dis; 1999 May; 58(5):288-90. PubMed ID: 10225813 [Abstract] [Full Text] [Related]
13. Sulphasalazine-induced lupus in psoriatic arthritis. Veale DJ, Ho M, Morley KD. Br J Rheumatol; 1995 Apr; 34(4):383-4. PubMed ID: 7788157 [Abstract] [Full Text] [Related]
14. Serologic subsets in systemic lupus erythematosus: an examination of autoantibodies in relationship to clinical features of disease and HLA antigens. Bell DA, Maddison PJ. Arthritis Rheum; 1980 Nov; 23(11):1268-73. PubMed ID: 6969593 [Abstract] [Full Text] [Related]
16. Sulphasalazine-induced autoimmune abnormalities in patients with rheumatic disease. Laversuch CJ, Collins DA, Charles PJ, Bourke BE. Br J Rheumatol; 1995 May; 34(5):435-9. PubMed ID: 7788172 [Abstract] [Full Text] [Related]
17. Arthritis and nephritis in patients with systemic lupus erythematosus. Kaplan D, Ginzler EM, Feldman J. J Rheumatol; 1991 Feb; 18(2):223-9. PubMed ID: 2023215 [Abstract] [Full Text] [Related]
18. Clinical features and antinuclear antibodies profile among adults with systemic lupus erythematosus and lupus nephritis: a cross-sectional study. Ahmed N, Shigidi M, Al Agib AN, Abdelrahman H, Taha E. Pan Afr Med J; 2017 Feb; 27():114. PubMed ID: 28819535 [Abstract] [Full Text] [Related]